Phase 2 AML, Childhood Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

AML, Childhood

Washington University School of Medicine68 enrolled1 locationNCT06158828

Recruiting

Phase 2

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Relapse/RecurrenceAML, ChildhoodRefractory AML+2 more

Children's Hospital of Soochow University50 enrolled12 locationsNCT06316960

Recruiting

Phase 2

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Acute Myeloid LeukemiaAML, Childhood

Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683